NCT00667199 2023-04-19
BAY88-8223, Does Response Study in HRPC Patients
Bayer
Phase 2 Completed
Clinical Trials
5 trialsNCT01741116 2021-02-18
Dovitinib(TKI258) in Patients With Castration-resistant Prostate Cancer
Korean Cancer Study Group
Phase 2 Completed
NCT00629525 2015-03-03
RAD001 in Patients With Metastatic, Hormone-Refractory Prostate Cancer
Duke University
Phase 2 Completed
NCT01215799 2011-12-15
PROACT
CytRx
Phase 2 Completed
NCT00407251 2010-11-05
Study of Patupilone in Prostate Cancer Patients Who Progress After Hormone Therapy and Docetaxel Chemotherapy
British Columbia Cancer Agency
Phase 2 Completed